9-93113021-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032310.5(CARD19):c.466G>A(p.Val156Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000101 in 1,609,382 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032310.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CARD19 | NM_032310.5 | c.466G>A | p.Val156Ile | missense_variant | 6/6 | ENST00000375464.7 | NP_115686.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CARD19 | ENST00000375464.7 | c.466G>A | p.Val156Ile | missense_variant | 6/6 | 1 | NM_032310.5 | ENSP00000364613 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152066Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000951 AC: 23AN: 241910Hom.: 0 AF XY: 0.0000991 AC XY: 13AN XY: 131186
GnomAD4 exome AF: 0.0000940 AC: 137AN: 1457316Hom.: 1 Cov.: 30 AF XY: 0.0000773 AC XY: 56AN XY: 724420
GnomAD4 genome AF: 0.000171 AC: 26AN: 152066Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74264
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2023 | The c.466G>A (p.V156I) alteration is located in exon 6 (coding exon 6) of the CARD19 gene. This alteration results from a G to A substitution at nucleotide position 466, causing the valine (V) at amino acid position 156 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at